M
Magoichi Sako
Researcher at Gifu Pharmaceutical University
Publications - 147
Citations - 1109
Magoichi Sako is an academic researcher from Gifu Pharmaceutical University. The author has contributed to research in topics: Pteridine & Bicyclic molecule. The author has an hindex of 16, co-authored 146 publications receiving 1058 citations. Previous affiliations of Magoichi Sako include University of Tokyo.
Papers
More filters
Journal ArticleDOI
Regioselective oxidative coupling of 4-hydroxystilbenes: synthesis of resveratrol and epsilon-viniferin (E)-dehydrodimers.
TL;DR: In this article, the authors used a short silica gel column to isolate 5-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol (resveratrol) with an equimolar amount of silver(I) acetate in dry MeOH at 50 °C for 1 h followed by chromatographic purification with a short gel column.
Journal ArticleDOI
An arylbenzofuran and four isoflavonoids from the roots of Erythrina poeppigiana.
Hitoshi Tanaka,Tomoko Oh-Uchi,Hideo Etoh,Magoichi Sako,Masaru Sato,Toshio Fukai,Yoichi Tateishi +6 more
TL;DR: Ery Poegin F is a rare 2-arylbenzofuran possessing a formyl group from a natural source, and erypoegin I is the first naturally occurring isoflavonoid with a 2-oxo-3-methylbutyl group.
Journal ArticleDOI
Identification of AMP N1-oxide in royal jelly as a component neurotrophic toward cultured rat pheochromocytoma PC12 cells.
Noriko Hattori,Hiroshi Nomoto,Satoshi Mishima,Shinsuke Inagaki,Masashi Goto,Magoichi Sako,Shoei Furukawa +6 more
TL;DR: AMP N 1-oxide is a key molecule that characterizes RJ, and is not found in natural products other than RJ, indicating that its actions are mediated by adenyl cyclase-coupled adenosine receptors, including A2 A.
Journal ArticleDOI
Photochemical oxygen-atom transfer reaction by heterocycle N-oxides involving a single-electron transfer process: oxidative demethylation of N,N-dimethylaniline
Journal ArticleDOI
Antibacterial properties of a new isoflavonoid from Erythrina poeppigiana against methicillin-resistant Staphylococcus aureus.
Hitoshi Tanaka,Masaru Sato,Tomoko Oh-Uchi,Ryozo Yamaguchi,Hideo Etoh,Hiroshi Shimizu,Magoichi Sako,H. Takeuchi +7 more
TL;DR: Findings suggest that compound 1 exhibits anti-MRSA activity by interfering with incorporation of metabolites and nutrients into bacterial cells or by affecting the nucleic acids of MRSA cells, which could be a potent phytotherapeutic agent for treating MRSA infections.